6.69
price up icon2.76%   0.18
after-market 시간 외 거래: 6.71 0.02 +0.30%
loading
전일 마감가:
$6.51
열려 있는:
$6.61
하루 거래량:
426.07K
Relative Volume:
1.02
시가총액:
$443.95M
수익:
$555.06M
순이익/손실:
$-39.48M
주가수익비율:
-11.15
EPS:
-0.6
순현금흐름:
$29.05M
1주 성능:
+3.24%
1개월 성능:
+7.90%
6개월 성능:
-42.72%
1년 성능:
-1.62%
1일 변동 폭
Value
$6.61
$6.795
1주일 범위
Value
$6.3341
$6.795
52주 변동 폭
Value
$5.28
$14.38

Bioventus Inc Stock (BVS) Company Profile

Name
명칭
Bioventus Inc
Name
전화
(919) 474-6700
Name
주소
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Name
직원
930
Name
트위터
Name
다음 수익 날짜
2025-03-11
Name
최신 SEC 제출 서류
Name
BVS's Discussions on Twitter

BVS을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Devices icon
BVS
Bioventus Inc
6.69 435.31M 555.06M -39.48M 29.05M -0.60
Medical Devices icon
ABT
Abbott Laboratories
133.58 231.14B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
102.09 154.60B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
383.89 146.12B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
87.44 105.64B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
77.52 45.60B 5.54B 4.18B 623.10M 7.00

Bioventus Inc Stock (BVS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-17 업그레이드 JP Morgan Underweight → Neutral
2023-12-07 업그레이드 Canaccord Genuity Hold → Buy
2023-08-09 업그레이드 Craig Hallum Hold → Buy
2022-11-22 다운그레이드 Craig Hallum Buy → Hold
2022-11-09 다운그레이드 Canaccord Genuity Buy → Hold
2022-11-09 다운그레이드 JP Morgan Overweight → Underweight
2022-03-15 개시 Craig Hallum Buy
2021-11-15 재개 Morgan Stanley Overweight
2021-11-10 재개 JP Morgan Overweight
2021-07-01 다운그레이드 Goldman Buy → Neutral
2021-03-08 개시 Canaccord Genuity Buy
2021-03-08 개시 Goldman Buy
2021-03-08 개시 JP Morgan Overweight
2021-03-08 개시 Morgan Stanley Overweight
모두보기

Bioventus Inc 주식(BVS)의 최신 뉴스

pulisher
02:42 AM

(BVS) Proactive Strategies - news.stocktradersdaily.com

02:42 AM
pulisher
10:44 AM

Bone Growth Stimulator Market Booming Worldwide with - openPR.com

10:44 AM
pulisher
Jun 04, 2025

bioventus inc. reports results of annual stockholders meeting By Investing.com - Investing.com India

Jun 04, 2025
pulisher
Jun 04, 2025

bioventus inc. reports results of annual stockholders meeting - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Bioventus Holds Annual Meeting, Elects Directors - TipRanks

Jun 04, 2025
pulisher
Jun 02, 2025

Cetera Investment Advisers Sells 1,805 Shares of Bioventus Inc. (NYSE:BVS) - Defense World

Jun 02, 2025
pulisher
May 30, 2025

Bioventus’ Cut Losses 46%, Organic Sales Up 5% - Orthopedics This Week

May 30, 2025
pulisher
May 30, 2025

Millennium Management LLC Sells 60,811 Shares of Bioventus Inc. (NYSE:BVS) - Defense World

May 30, 2025
pulisher
May 26, 2025

Janus Henderson Group PLC Acquires Shares of 17,200 Bioventus Inc. (NYSE:BVS) - Defense World

May 26, 2025
pulisher
May 19, 2025

Balyasny Asset Management L.P. Invests $133,000 in Bioventus Inc. (NYSE:BVS) - Defense World

May 19, 2025
pulisher
May 19, 2025

BNP Paribas Financial Markets Invests $1.66 Million in Bioventus Inc. (NYSE:BVS) - Defense World

May 19, 2025
pulisher
May 18, 2025

Price T Rowe Associates Inc. MD Has $160,000 Stock Holdings in Bioventus Inc. (NYSE:BVS) - Defense World

May 18, 2025
pulisher
May 16, 2025

(BVS) On The My Stocks Page - news.stocktradersdaily.com

May 16, 2025
pulisher
May 12, 2025

Bioventus reiterates 2025 guidance with focus on growth and profitability - MSN

May 12, 2025
pulisher
May 08, 2025

Barclays PLC Has $696,000 Holdings in Bioventus Inc. (NYSE:BVS) - Defense World

May 08, 2025
pulisher
May 07, 2025

Bioventus (BVS) Price Target Trimmed by Craig-Hallum Analyst | BVS Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Bioventus Inc. (NASDAQ:BVS) Q1 2025 Earnings Call Transcript - Insider Monkey

May 07, 2025
pulisher
May 07, 2025

Is Bioventus (NASDAQ:BVS) Using Too Much Debt? - simplywall.st

May 07, 2025
pulisher
May 07, 2025

Bioventus First Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Bioventus Inc (BVS) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Divestitures - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Bioventus Inc (BVS) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Divestitures By GuruFocus - Investing.com Canada

May 07, 2025
pulisher
May 07, 2025

Bioventus Reports Q1 2025 Financial Performance - TipRanks

May 07, 2025
pulisher
May 07, 2025

Bioventus: Q1 Earnings Snapshot - CTPost

May 07, 2025
pulisher
May 06, 2025

Bioventus Earnings Call: Growth Amid Challenges - TipRanks

May 06, 2025
pulisher
May 06, 2025

Financial Fitness Check: Examining Bioventus Inc (BVS)’s Key Ratios - DWinneX

May 06, 2025
pulisher
May 06, 2025

Bioventus earnings beat by $0.04, revenue topped estimates - Investing.com Canada

May 06, 2025
pulisher
May 06, 2025

Bioventus Q1 2025 slides: 5% organic growth despite revenue decline, maintains guidance - Investing.com Canada

May 06, 2025
pulisher
May 06, 2025

Earnings call transcript: Bioventus Q1 2025 beats EPS forecast but faces stock dip - Investing.com Nigeria

May 06, 2025
pulisher
May 06, 2025

Bioventus Inc. Q1 Loss Narrows - Nasdaq

May 06, 2025
pulisher
May 06, 2025

Bioventus (BVS) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance

May 06, 2025
pulisher
May 06, 2025

Bioventus (BVS) Exceeds Q1 Revenue Expectations with Strong Perf - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Bioventus Inc Q1 2025 Earnings: Revenue Hits $123.9M, Beating Es - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Bioventus (BVS) Exceeds Q1 Revenue Expectations with Strong Performance | BVS Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Bioventus reports Q1 revenue and earnings above estimates, shares dip By Investing.com - Investing.com Nigeria

May 06, 2025
pulisher
May 06, 2025

Bioventus reports Q1 revenue and earnings above estimates, shares dip - Investing.com Australia

May 06, 2025
pulisher
May 06, 2025

Bioventus Reports First Quarter Financial Results | BVS Stock Ne - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Bioventus Reports First Quarter Financial Results - The Manila Times

May 06, 2025
pulisher
May 06, 2025

Bioventus Reports First Quarter Financial Results | BVS Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Bioventus Inc. Reports Q1 2025 Financial Results: Revenue Decline of 4.3% but Organic Growth of 5.0% and Improved Non-GAAP EPS - Nasdaq

May 06, 2025
pulisher
May 06, 2025

Bioventus Inc. SEC 10-Q Report - TradingView

May 06, 2025
pulisher
May 06, 2025

(BVS) Trading Report - news.stocktradersdaily.com

May 06, 2025
pulisher
May 05, 2025

Examining the Future: Bioventus's Earnings Outlook - Nasdaq

May 05, 2025
pulisher
May 05, 2025

Bioventus Inc (BVS) Q1 2025 Earnings Report Preview: What To Look For - GuruFocus

May 05, 2025
pulisher
May 02, 2025

Bioventus Inc expected to post earnings of 2 cents a shareEarnings Preview - TradingView

May 02, 2025
pulisher
May 01, 2025

Legal & General Group Plc Raises Position in Bioventus Inc. (NYSE:BVS) - Defense World

May 01, 2025
pulisher
Apr 29, 2025

Orthobiologics Market Growth Statistics & Future Prospects | Medtronic, Orthofix Medical, Bioventus - openPR.com

Apr 29, 2025
pulisher
Apr 28, 2025

Bioventus Q1 2025 Earnings Preview: Key Metrics and Business Updates Coming May 6 - Stock Titan

Apr 28, 2025
pulisher
Apr 28, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 28, 2025

Bioventus Inc (BVS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Bioventus Inc 주식 (BVS) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
SUTTER MARTIN P
Director
Jun 02 '25
Option Exercise
0.00
26,493
0
85,241
STALNECKER SUSAN M
Director
Jun 02 '25
Option Exercise
0.00
26,493
0
105,957
NOHRA GUY P
Director
Jun 02 '25
Option Exercise
0.00
26,493
0
126,610
NEELS GUIDO J
Director
Jun 02 '25
Option Exercise
0.00
26,493
0
85,241
McMurry-Heath Michelle
Director
Jun 02 '25
Option Exercise
0.00
26,493
0
74,698
Ladone Mary Kay
Director
Jun 02 '25
Option Exercise
0.00
26,493
0
78,981
HAWKINS WILLIAM A
Director
Jun 02 '25
Option Exercise
0.00
26,493
0
257,851
Beyer Pat
Director
Jun 02 '25
Option Exercise
0.00
26,493
0
76,436
Singleton Mark Leonard
SVP & CFO
Apr 11 '25
Sale
7.57
3,875
29,334
141,088
D'Adamio Anthony
SVP & General Counsel
Apr 11 '25
Sale
7.57
2,958
22,392
131,416
medical_devices PHG
$23.46
price up icon 0.56%
medical_devices STE
$243.72
price up icon 0.06%
medical_devices SNN
$30.26
price down icon 0.13%
$71.62
price up icon 0.10%
$86.67
price up icon 1.08%
medical_devices EW
$77.52
price down icon 0.32%
자본화:     |  볼륨(24시간):